去铁胺治疗骨髓增生异常综合征 - Suppr

Suppr

超能文献

Desferrioxamine in the treatment of myelodysplastic syndromes.

作者信息

Del Río Garma J, Fernandez Lago C, Batlle Fonrodona F J

出版信息

Haematologica. 1997 Sep-Oct;82(5):639-40.

PMID:9407744

Abstract

摘要

相似文献

Desferrioxamine in the treatment of myelodysplastic syndromes.去铁胺治疗骨髓增生异常综合征

Haematologica. 1997 Sep-Oct;82(5):639-40.

Correction of anemia in a transfusion-dependent patient with primary myelofibrosis receiving iron chelation therapy with deferasirox (Exjade, ICL670).在接受地拉罗司（恩瑞格，ICL670）铁螯合治疗的原发性骨髓纤维化输血依赖患者中纠正贫血。

Eur J Haematol. 2007 Jun;78(6):540-2. doi: 10.1111/j.1600-0609.2007.00840.x. Epub 2007 Mar 28.

Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload.骨髓增生异常综合征及输血性铁过载患者铁螯合治疗指南。

Leuk Res. 2007 Dec;31 Suppl 3:S10-5. doi: 10.1016/S0145-2126(07)70461-7.

Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality.一项针对日本输血依赖型骨髓增生异常综合征和再生障碍性贫血患者的全国性回顾性调查凸显了铁过载对发病率/死亡率的负面影响。

Eur J Haematol. 2007 Jun;78(6):487-94. doi: 10.1111/j.1600-0609.2007.00842.x. Epub 2007 Mar 28.

Iron overload in myelodysplastic syndromes: a Canadian consensus guideline.骨髓增生异常综合征中的铁过载：加拿大共识指南

Leuk Res. 2008 Sep;32(9):1338-53. doi: 10.1016/j.leukres.2008.02.021. Epub 2008 Apr 11.

Danazol therapy in myelodysplastic syndromes.达那唑治疗骨髓增生异常综合征

Haematologica. 1992 Jan-Feb;77(1):96.

Improving clinical outcome in patients with myelodysplastic syndrome and iron overload using iron chelation therapy.使用铁螯合疗法改善骨髓增生异常综合征和铁过载患者的临床结局。

Leuk Res. 2007 Dec;31 Suppl 3:S7-9. doi: 10.1016/S0145-2126(07)70460-5.

Subcutaneous bolus injection of deferoxamine in adult patients affected by onco-hematologic diseases and iron overload.对患有肿瘤血液疾病和铁过载的成年患者进行去铁胺皮下大剂量注射。

Haematologica. 1998 Sep;83(9):788-90.

Iron chelation therapy in patients with myelodysplastic syndromes: consensus conference guidelines.骨髓增生异常综合征患者的铁螯合治疗：共识会议指南

Isr Med Assoc J. 2008 May;10(5):374-6.

[Supportive therapy for myelodysplastic syndrome (MDS). Indispensable pillar in the multimodal treatment concept].[骨髓增生异常综合征（MDS）的支持性治疗。多模式治疗理念中不可或缺的支柱]

Pharm Unserer Zeit. 2010 May;39(3):228-33. doi: 10.1002/pauz.201000370.

引用本文的文献

Durable Red Blood Cell Transfusion Independence in a Patient with an MDS/MPN Overlap Syndrome Following Discontinuation of Iron Chelation Therapy.停用铁螯合疗法后，一名骨髓增生异常综合征/骨髓增殖性肿瘤重叠综合征患者实现持久的红细胞输注独立。

Case Rep Hematol. 2015;2015:253294. doi: 10.1155/2015/253294. Epub 2015 Mar 30.

Optimizing therapy for iron overload in the myelodysplastic syndromes: recent developments.优化骨髓增生异常综合征铁过载的治疗：最新进展。

Drugs. 2011 Jan 22;71(2):155-77. doi: 10.2165/11585280-000000000-00000.

Iron overload in patients with myelodysplastic syndromes.骨髓增生异常综合征患者的铁过载。

Curr Hematol Malig Rep. 2007 Feb;2(1):13-21. doi: 10.1007/s11899-007-0003-5.

Red blood cell transfusion independence following the initiation of iron chelation therapy in myelodysplastic syndrome.骨髓增生异常综合征患者开始铁螯合治疗后实现红细胞输注独立

Adv Hematol. 2010;2010:164045. doi: 10.1155/2010/164045. Epub 2010 Mar 23.

Iron chelation therapy in the myelodysplastic syndromes and aplastic anemia: a review of experience in South Korea.骨髓增生异常综合征和再生障碍性贫血中的铁螯合疗法：韩国经验综述

Int J Hematol. 2008 Jul;88(1):16-23. doi: 10.1007/s12185-008-0117-0. Epub 2008 Jul 5.

Optimal management strategies for chronic iron overload.慢性铁过载的最佳管理策略。

Drugs. 2007;67(5):685-700. doi: 10.2165/00003495-200767050-00004.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验